Company attributes
Location
Parent Organization
Number of Employees (Ranges)
51 – 200
Email Address
BD@crisprtx.com
Other attributes
Company Operating Status
Active
Casebia Therapeutics is a gene editing therapeutics company founded by CRISPR Therapeutics and Bayer, focused on blood disorders, blindness, congenital heart disease and autoimmune disease. Casebia is developing gene-editing therapies for hemophilia, blindness and a rare autoimmune disorder. The company is managed by CRISPR Therapeutics.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
